Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Business
Bradley Gerrard

HISTORICAL FACTS: Glaxosmithkline and astrazeneca secure victories with us drug regulator - Caught on Camera

GlaxoSmithKline and rival AstraZeneca have both received positive updates from the US Food and Drug Administration for two drugs.

(Picture: PA)

GlaxoSmithKline and AstraZeneca have secured victories with the US regulator in relation to treatments that could become blockbuster drugs for the firms.

Glaxo’s Daprodustat, which is used for the treatment of anaemia in chronic kidney disease patient, has had its application for approval accepted by the Food and Drug Administration (FDA) in the US after its successful phase III clinical trial.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.